| Trial | UCB6114 CRUKD24002 |
|---|---|
| Cancer Type | Pancreatic Cancer |
| Hospital(s) | Belfast City Hospital |
| Information | A Cancer Research UK Phase II open label trial in participants with metastatic pancreatic ductal adenocarcinoma of ginisortamab given intravenously with i) first-line standard of care nab-paclitaxel and gemcitabine, or ii) in combination with MEK inhibitor maintenance therapy |
 |
Click Here to view Cancer Research UK trial summary |
| Trial | UK P3BEP |
|---|---|
| Cancer Type | Genitourinary and Miscellaneous |
| Hospital(s) | Belfast City Hospital |
| Information | A randomized phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours |
|
Click Here to view Cancer Research UK trial summary |
| Trial | UMBRELLA |
|---|---|
| Cancer Type | Children’s Cancer |
| Hospital(s) | Royal Belfast Hospital for Sick Children |
| Information | A SIOP Renal Tumours Study Group Prospective Clinical Study. |
|
Click Here to view Cancer Research UK trial summary |
| Trial | VICTOR |
|---|---|
| Cancer Type | Haematological Cancers and Leukaemia |
| Hospital(s) | Belfast City Hospital |
| Information | Venetoclax or Intensive Chemotherapy For Treatment of Favourable Risk Acute Myeloid Leukaemia: A Molecularly Guided Phase 2 Study |
| Trial | VIVO Biobank |
|---|---|
| Cancer Type | Children’s Cancer, Miscellaneous, and Non-specific |
| Hospital(s) | Royal Belfast Hospital for Sick Children |
| Information | A UK Biobank dedicated to cancer research in children and young people |
|
Click Here to view Cancer Research UK trial summary |
‹ Previous 1 2 3 4